Development and introduction of inactivated poliovirus vaccines derived from Sabin strains in Japan
- PMID: 25448090
- DOI: 10.1016/j.vaccine.2014.11.015
Development and introduction of inactivated poliovirus vaccines derived from Sabin strains in Japan
Abstract
During the endgame of global polio eradication, the universal introduction of inactivated poliovirus vaccines is urgently required to reduce the risk of vaccine-associated paralytic poliomyelitis and polio outbreaks due to wild and vaccine-derived polioviruses. In particular, the development of inactivated poliovirus vaccines (IPVs) derived from the attenuated Sabin strains is considered to be a highly favorable option for the production of novel IPV that reduce the risk of facility-acquired transmission of poliovirus to the communities. In Japan, Sabin-derived IPVs (sIPVs) have been developed and introduced for routine immunization in November 2012. They are the first licensed sIPVs in the world. Consequently, trivalent oral poliovirus vaccine was used for polio control in Japan for more than half a century but has now been removed from the list of vaccines licensed for routine immunization. This paper reviews the development, introduction, characterization, and global status of IPV derived from attenuated Sabin strains.
Keywords: Global polio eradication; Inactivated poliovirus vaccine; Oral poliovirus vaccine; Poliovirus; Poliovirus vaccine; Sabin strain; Vaccine-associated paralytic poliomyelitis; Vaccine-derived poliovirus.
Copyright © 2014 Elsevier Ltd. All rights reserved.
Similar articles
-
[Universal use of inactivated poliovirus vaccine--the needs and challenges].Nihon Rinsho. 2008 Oct;66(10):1950-5. Nihon Rinsho. 2008. PMID: 18939495 Review. Japanese.
-
Risks associated with the use of live-attenuated vaccine poliovirus strains and the strategies for control and eradication of paralytic poliomyelitis.Expert Rev Vaccines. 2012 May;11(5):609-28. doi: 10.1586/erv.12.28. Expert Rev Vaccines. 2012. PMID: 22827246 Review.
-
The polio endgame.Hum Vaccin Immunother. 2014;10(7):2106-8. doi: 10.4161/21645515.2014.981115. Hum Vaccin Immunother. 2014. PMID: 25608050 Free PMC article. Review.
-
An Introduction to Poliovirus: Pathogenesis, Vaccination, and the Endgame for Global Eradication.Methods Mol Biol. 2016;1387:1-10. doi: 10.1007/978-1-4939-3292-4_1. Methods Mol Biol. 2016. PMID: 26983727
-
[End phase challenges of poliomyelitis eradication programme realization].Przegl Epidemiol. 2005;59(1):59-68. Przegl Epidemiol. 2005. PMID: 16013411 Review. Polish.
Cited by
-
Inactivated Poliovirus Vaccine: Recent Developments and the Tortuous Path to Global Acceptance.Pathogens. 2024 Mar 4;13(3):224. doi: 10.3390/pathogens13030224. Pathogens. 2024. PMID: 38535567 Free PMC article. Review.
-
Immune Persistence following Primary Immunization and the Immunogenicity and Safety of a Booster Dose of a Multidose Sabin Strain-Based Inactivated Polio Vaccine in Infants Aged 18 Months.Vaccines (Basel). 2024 Jan 25;12(2):123. doi: 10.3390/vaccines12020123. Vaccines (Basel). 2024. PMID: 38400106 Free PMC article.
-
Screening of a new candidate coxsackievirus B1 vaccine strain based on its biological characteristics.Front Microbiol. 2023 Jul 12;14:1172349. doi: 10.3389/fmicb.2023.1172349. eCollection 2023. Front Microbiol. 2023. PMID: 37502400 Free PMC article.
-
Current and next-generation formulation strategies for inactivated polio vaccines to lower costs, increase coverage, and facilitate polio eradication.Hum Vaccin Immunother. 2022 Dec 30;18(7):2154100. doi: 10.1080/21645515.2022.2154100. Epub 2022 Dec 28. Hum Vaccin Immunother. 2022. PMID: 36576132 Free PMC article. Review.
-
Immunogenicity of Catch-Up Immunization with Conventional Inactivated Polio Vaccine among Japanese Adults.Vaccines (Basel). 2022 Dec 15;10(12):2160. doi: 10.3390/vaccines10122160. Vaccines (Basel). 2022. PMID: 36560570 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
